With a commitment to precision medicine, and a combined 35 years of CRO experience, we are at the forefront of driving advancements in liquid biopsy translational science, clinical research, and diagnostics. At LuminoDx we specialize in leveraging cutting edge technologies for exosome isolation and downstream molecular analysis. This includes high content proteomics with O-link’s Signature platform (certified O-link service provider), flow cytometry, and advanced nucleic acid detection platforms like ddPCR.
Leading the Way in Advanced Translational and Clinical Research Services
At LuminoDx, we are an experienced team, motivated by a passion for using scientific innovations to successfully support therapeutic development. We offer best in class next gen liquid biopsy solutions including exosome isolation, and advanced clinical testing. By leading the way in next-gen liquid biopsy biomarker discovery and development, we are helping to shape the future of precision diagnostics.
Top-quality data, guaranteed.
We provide services from biomarker discovery to the commercialization of the test.